These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 568198)

  • 1. [Prostaglandin E1 therapy in infants with cyanotic congenital heart malformations: hemodynamic and angiographic findings (author's transl)].
    Schumacher G; Mocellin R; Schöber JG; Kellner M; Bühlmeyer K
    Klin Padiatr; 1978 Sep; 190(5):465-73. PubMed ID: 568198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of prostaglandin E1 on the hemodynamics in newborn infants with pulmonary atresia (author's transl)].
    Mocellin R; Sauer U; Schumacher G; Kellner M; Schöber JG
    Z Kardiol; 1978 Aug; 67(8):572-7. PubMed ID: 695809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostaglandin E1: effect on blood gases in infants with cyanotic congenital heart disease (author's transl)].
    Schöber JG; Kellner M; Christian I
    Klin Padiatr; 1977 Sep; 189(5):365-9. PubMed ID: 21323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged prostaglandin E1 infusion in an infant with cyanotic congenital heart disease.
    Lewis AB; Lurie PR
    Pediatrics; 1978 Apr; 61(4):534-6. PubMed ID: 662477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia.
    Heymann MA; Rudolph AM
    Pediatrics; 1977 Mar; 59(3):325-9. PubMed ID: 840551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
    Noah ML
    Adv Prostaglandin Thromboxane Res; 1978; 4():355-62. PubMed ID: 347914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease.
    Friedman AH; Fahey JT
    Semin Perinatol; 1993 Apr; 17(2):106-21. PubMed ID: 8327901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease.
    Graham TP; Atwood GF; Boucek RJ
    South Med J; 1978 Oct; 71(10):1238-41, 1246. PubMed ID: 81528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of prostaglandin in heart abnormalities with needed patency of the arterial canal (clinical and histological study)].
    Moulaert A; Gittenberger-De Groot A; Harinck E
    Arch Fr Pediatr; 1978; 35(7):717-25. PubMed ID: 736728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prostaglandin E1 and E2 in the management of neonatal heart disease.
    Olley PM; Coceani F; Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():345-53. PubMed ID: 645511
    [No Abstract]   [Full Text] [Related]  

  • 12. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
    Maesen Y; Bosi G; Stijns M; Vliers A
    Arch Mal Coeur Vaiss; 1981 May; 74(5):579-85. PubMed ID: 6794479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin E1 in infants with pulmonary atresia.
    Weir EK; Matisonn RE; Losman E; Chesler E
    S Afr Med J; 1978 Oct; 54(17):700-2. PubMed ID: 741285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of E1 type prostaglandin on hypoxemia in a cyanotic congenital cardiac malformation.
    Moulaert A; Senders R; van Ertbruggen I; Huysmans H; Harinck E
    Eur J Cardiol; 1977 Jun; 5(4):321-5. PubMed ID: 891577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vascular and hemodynamic effects of prostaglandin E1 in unanesthetized sheep.
    Ogletree ML; Brigham KL
    Microcirc Endothelium Lymphatics; 1984 Jun; 1(3):307-27. PubMed ID: 6546148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of prolonged infusion of prostaglandin E1 (PGE1) after hemorrhagic shock.
    Machiedo GW; Warden MJ; LoVerme PJ; Rush BF
    Adv Shock Res; 1982; 8():171-6. PubMed ID: 6890304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.